Daniel Loeb

Daniel Loeb

Last Update: 2014-08-21

Number of Stocks: 41
Number of New Stocks: 11

Total Value: $8,133 Mil
Q/Q Turnover: 38%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Daniel Loeb' s Profile & Performance

Profile

Daniel S. Loeb founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio, and risk management. He is well known for his public letters in which he criticizes company CEOs or other investment managers. Third Point’s total assets are more than $2.2 billion, and Loeb’s personal net worth is $2.3 billion.

Web Page:http://www.thirdpointpublic.com/

Investing Philosophy

Loeb and Third Point focus on activist investing, and follows an event-driven, value-oriented investment style. Loeb identifies situations in which a catalyst will unlock value.

Total Holding History

Performance of Master Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
201325.231.55-6.3
201221.215.45.8
2011-0.12.08-2.2
3-Year Cumulative51.6 (14.9%/year)55 (15.7%/year)-3.4 (-0.8%/year)
201033.515.0618.4
200938.226.4611.7
5-Year Cumulative179.7 (22.8%/year)125.5 (17.7%/year)54.2 (5.1%/year)
2008-32.8-374.2
200716.65.6111.0
20061515.79-0.8
200519.94.9115.0
200430.21218.2
10-Year Cumulative293.4 (14.7%/year)104.1 (7.4%/year)189.3 (7.3%/year)
200351.528.722.8
2002-7-22.115.1
200114.9-11.926.8
200017.1-9.126.2
199942.22121.2
15-Year Cumulative960.5 (17%/year)98.3 (4.7%/year)862.2 (12.3%/year)
19986.628.6-22.0
199752.133.418.7
199644.32321.3
19953737.6-0.6

Top Ranked Articles

Market Cycle Analysis & Five-Year Rolling Analysis of Guru Performance
Market Cycle Analysis In our research of John Hussman’s performance, we observed that he underperformed the market if we look at the latest 3-year annualized return, 5-year annualized return and even 10-year annualized return. Yet this might not be the case if we look at his performance over a complete economic cycle. Read more...
Dan Loeb’s Letter to the Board of Yahoo
LETTER TO THE BOARD OF DIRECTORS OF THE ISSUER Read more...
Talks of Carl Icahn Getting a Piece of Herbalife, Joining Loeb in Long Position
After fellow activist investor, Daniel Loeb set off the media earlier this week with his declaration to obtain a long position in Herbalife (HLF), a company that Pershing Square’s Bill Ackman just shorted weeks ago, corporate raiding Guru Carl Icahn has been reported yesterday afternoon of joining Loeb in taking a piece of the action. Read more...
Daniel Loeb Comments on AIG
Equity: AIG (AIG) Read more...
Why Third Point Capital's Daniel Loeb Is Beating John Paulson and David Einhorn
On Wednesday, Reuters reported that hedge funds overall have lost an average of 2% over the first half of the year, while the S&P gained around 6%. Below the average are unexpected names like John Paulson (flagship fund down 15%), David Einhorn (Greenlight Capital down 5%), and Bill Ackman (Pershing Square Capital down 2.27%). Read more...
» More Daniel Loeb Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Dow Chemical´s Promising Future
In this article, let's take a look at The Dow Chemical Company (DOW), a $65.41 billion market cap company, which is the largest U.S. chemical company and provides chemical, plastic andagricultural products as well as services. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Daniel Loeb's New Stocks Daniel Loeb - Daniel Loeb's New Stocks
Dan Loeb is CEO of Third Point LLC, founded in 1995, where he oversees all investment activity. Third Point describes its underlying strategy as “event-driven, value-oriented,” and says it “seeks to identify situations where we anticipate a catalyst will unlock value,” on its website. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Top Hedge Fund Managers Are Buying Ally Financial Daniel Loeb,George Soros - Top Hedge Fund Managers Are Buying Ally Financial
Now that the investment management firms have filed their Form 13Fs with the SEC, we can gain better insight into which securities the investing gurus are buying and selling. The S&P 500 Grid at GuruFocus can be used to find the top buys, sells and net buys based on a number of different categories. More...

  • Currently 3.25/5

Rating: 3.3/5 (4 votes)

Which Is The Better Buy?: Einhorn's Greenlight Re or Loeb's Third Point Re Daniel Loeb - Which Is The Better Buy?: Einhorn's Greenlight Re Or Loeb's Third Point Re
Within the past week both Greenlight Re (GLRE) and Third Point Re (TPRE) released their second quarter earnings for 2014. The reinsurance companies both have investing gurus we follow running the investment portfolios. David Einhorn handles the portfolio for Greenlight Re, and Daniel Loeb is in charge of Third Point Re’s portfolio. Einhorn and Loeb started their long/short hedge funds in the mid-1990s and have had annual gains of about 20 percent each since inception. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Global Market Valuations And Expected Returns - August 6, 2014 Daniel Loeb - Global Market Valuations And Expected Returns - August 6, 2014
In January 2014, the U.S. stock market benchmark S&P 500 lost 3.36% after the excellent 2013. The enthusiasm went back as the market gained 4.31% over February. In March, it went up only 0.69%. In April, it was about even for the whole month. In May, the market gained 2.10% and in June, the market benchmark S&P 500 went up 1.91%. However, in July, the market went down by 1.51%. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Third Point Comments on Royal DSM NV
Over the past three years, Royal DSM NV (“DSM”) has transformed itself into a leading global life sciences company focused on health and nutrition with ~$12 billion of sales and ~$1.7 billion of EBITDA. DSM’s portfolio of businesses also includes legacy activities in materials sciences. While the Materials segments account for ~55% of sales, their profit contribution to the DSM group (~30% of EBITDA) has been greatly surpassed by that of the Nutrition segment (~70% of EBITDA). Earlier this year, DSM shares sold-off following: i) a profit warning in the Nutrition segment, and ii) growing skepticism about DSM’s ability to execute on its plan to divest its commodity caprolactam business. The weakness in DSM’s share price served as an opportunity to build our position. We believe that the profit warning in Nutrition was driven by cyclical factors and abnormally adverse weather rather than any structural changes in the underlying fundamentals. We are also optimistic that management can successfully separate its commodity caprolactam exposure through either a sale or joint venture. Finally, near-term trends are positive More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Daniel Loeb’s Third Point Second Quarter 2014 Investor Letter
Review and Outlook More...

  • Currently 1.75/5

Rating: 1.8/5 (4 votes)

Einhorn Is Transforming BioFuel Energy Into A Profitable Real Estate Company Daniel Loeb - Einhorn Is Transforming BioFuel Energy Into A Profitable Real Estate Company
Two of the gurus that I follow at GuruFocus are David Einhorn and Daniel Loeb. They are both considered to be activist investors and their hedge funds have experienced extraordinary results. Loeb started Third Point Capital in 1995 and Einhorn started Greenlight Capital in 1996. Third Point Capital has returned 20.4 percent annulized since its inception in 1995, and Greenlight Capital has returned 19.5 percent annualized since May of 1996. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Top Insider Sells Highlight: Cytec Industries Inc.
Vice President and CFO of Cytec Industries Inc. (CYT) David Drillock sold 49,038 shares on July 21 at an average price of $107.06. The total transaction amount was $5,250,008. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Top Insider Sells Highlight: Google Inc.
CEO and 10% Owner of Google Inc (GOOG) Lawrence Page sold 33,332 shares on July 14 at an average price of $586.48. The total transaction amount is $19,548,551. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Gain Access to Daniel Loeb’s Hedge Fund Through Third Point Re Daniel Loeb - Gain Access To Daniel Loeb’s Hedge Fund Through Third Point Re
Through my research of Greenlight Re (GLRE), I discovered Third Point Reinsurance (TPRE). Third Point Re was listed as the most similar, publicly traded competitor to Greenlight Re. The company is a way to gain access to Daniel Loeb’s hedge fund without needing the typical $1 million to invest in such a fund. Loeb has been one of the best performing gurus that we follow at GuruFocus. Third Point’s funds have blown away the S&P 500 over the years. The Master Fund has provided an annual return of 20.4 percent since inception in 1995 compared to the S&P 500’s annual return of 9.7 percent. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

  • Currently 4.67/5

Rating: 4.7/5 (3 votes)

Top 5 Hedge Fund Net Buys Daniel Loeb,Joel Greenblatt - Top 5 Hedge Fund Net Buys
The recent top net buys of the hedge fund gurus were American Airlines (AAL), Actavis (ACT), Allegion (ALLE), Gilead Sciences (GILD), and Verizon (VZ). I found the net buys by using the S&P 500 Grid at GuruFocus. I adjusted the setting to include only hedge fund gurus and examined the results for both S&P 500 companies and non-S&P 500 companies. More...

  • Currently 4.50/5

Rating: 4.5/5 (2 votes)

Can Loeb Reinvigorate Sotheby’s? Daniel Loeb - Can Loeb Reinvigorate Sotheby’s?
Now that Third Point LLC’s founder and CEO, Daniel Loeb, and the board of Sotheby’s (BID) have come to an agreement, is now the time to buy the stock? There is currently an opportunity to buy it at a lower price than Loeb. He currently has 6.35 million shares valued at valued a little under $260 million. His average purchase price is $43.91 with his purchases starting in February of 2013. The stock is now trading for about 7 percent less at $40.76. More...

  • Currently 4.00/5

Rating: 4.0/5 (1 vote)

Daniel Loeb Comments on SoftBank Corp
SoftBank Corp. (TSE:9984)("SoftBank") Update Following its strong rally at year‐end, SoftBank shares pulled back 15% during Q1 2014. We believe this pullback was due to technical trading and that SoftBank's fundamentals are stronger than when we initiated the position during the fourth quarter of 2013. SoftBank has continued to demonstrate significant value growth in key drivers across each of its underlying businesses. The Japanese wireless segment successfully navigated the temporary impact of NTT's iPhone offering and seasonal promotional activity in March 2014, while consensus valuations for Alibaba Group have grown from $120 billion to $171 billion year‐to‐date. These trends play into the four‐pronged equity value expansion story for SoftBank shares: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Daniel Loeb Comments on IHI Corporation
Equity Position: IHI Corporation ("IHI")(TSE:7013) More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Third Point (Dan Loeb) Q1 2014 Letter to Investors
  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Global Market Valuations and Expected Returns – April 4, 2014 Daniel Loeb,Francis Chou - Global Market Valuations And Expected Returns – April 4, 2014
In January 2014, the U.S. stock market benchmark S&P 500 lost 3.36% after an excellent 2013. The enthusiasm went back as the market gained 4.31% over February. In March, it went up only 0.69%. The market benchmark S&P 500 closed at 1890.90 on April 2, 2014, which is the new record high. What is the situation in the other parts of the world? In March, the key indexes in Europe returned negative. Germany’s DAX index declined 1.40%. France’s CAC-40 index lost 0.38%. The FTSE 100 index was down 3.10%. Stock market performances in Asia were weak too. Japan’s NIKKEI 225 moderately decreased 0.09%. Hong Kong’s Hang Seng Index was down 3.00% and China’s SSE Composite index was down 1.12% due to the weaker-than-expected Chinese economic data. More...

  • Currently 5.00/5

Rating: 5.0/5 (3 votes)

Big Solutions to Improve Dow's Balance Sheet
The Dow Chemical Company (DOW) is the largest U.S. chemical maker by sales. It is engaged in manufacturing and supplying products used primarily as raw materials in the manufacture of customer products and services. The company serves the following industries: appliance; automotive; agricultural; building and construction; chemical processing; electronics; furniture; housewares; oil and gas; packaging; paints, coatings and adhesives; personal care; pharmaceutical; processed foods; pulp and paper; textile and carpet; utilities; and water treatment. More...

LONG, CHEMICALS


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK